Wednesday, 7 October 2026
YHDP YHDP Preventive medicine information
and vaccination for everyone
Vaccines

Shingrix (RZV)

Recombinant shingles vaccine · GlaxoSmithKline (GSK)

Private market Use with caution, only when indicated

Prevents

Dosing schedules

2-dose schedule for people aged 18–49 at increased risk of shingles

For: People with chronic conditions

DoseAgeMinimum interval from previous dose
Dose 1 (Shingrix) When a doctor determines the person is at increased risk of shingles –
Dose 2 (Shingrix) 1 to 6 months after dose 1 30 days

Only for people at increased risk of shingles (immunocompromised, on immunosuppressive drugs, underlying conditions) as prescribed by a doctor. Immunocompromised or immunosuppressed people can receive dose 2 earlier, after 1–2 months.

Source: Recommended vaccination schedules for all ages in Vietnam (2026 edition). Reviewed on 07/10/2026.

2-dose schedule for people aged 50 and over (2–6 months apart)

For: Adults (18–59 years)

DoseAgeMinimum interval from previous dose
Dose 1 (Shingrix) 50 years –
Dose 2 (Shingrix) 2 to 6 months after dose 1 60 days

For people aged 50 and over, including older adults. People who have had shingles should still be vaccinated once the episode is over. Intramuscular, 0.5 ml per dose.

Source: Recommended vaccination schedules for all ages in Vietnam (2026 edition). Reviewed on 07/10/2026.

Calculate your dates

Special precautions

Indicated from 50 years of age, or from 18 years for people at increased risk. 2 intramuscular doses 2–6 months apart.

Contraindications and deferrals

  • Contraindication Severe hypersensitivity to the active substance or to the AS01B adjuvant
    Absolute contraindication.

Pregnancy and breastfeeding

Insufficient data